Back to results

General Chapters – Dosage Forms – Subvisible Expert Panel - Expert Advisor

  • Rockville, MD, United States
Apply on recruiting.ultipro.com About employer

Applications open in a new tab.

Job details

Posting language
English
Posted

Original job description

2025-2030 Focus:

  • Modernize USP guidance for subvisible particulate matter and strengthen science- and risk-based best practices.
  • Reimagine the USP <1788> series to better address current products and emerging modalities.
  • Clarify particle classification and limits, especially inherent vs. intrinsic/extrinsic particles.
  • Address silicone oil droplets, including analytical approaches and FDA feedback. Develop modality-specific approaches for ophthalmics, cell & gene therapy, LNPs, viral vectors, and combination products.
  • Advance particle characterization, including sub-10 &micro;m particles, particle ID, and complementary methods beyond light obscuration.
  • Connect particles to clinical risk and control strategies, including packaging/device contributions and process sampling.
  • Coordinate visible and subvisible particle standards toward a more coherent USP particulate-matter framework.

2025-2030 Key Issues:

  • USP <1788> modernization: reimagining the informational chapter series for current and emerging products.
  • Particle classification & limits: clarifying inherent, intrinsic, and extrinsic particles and how limits should apply.
  • Silicone oil droplets: analytical strategies, characterization, and appropriate USP guidance.
  • Emerging modalities: addressing challenges with cell & gene therapies, LNPs, viral vectors, and other complex products.
  • Ophthalmics: developing appropriate approaches for subvisible particles in ophthalmic products.
  • Measurement & characterization: light obscuration, flow imaging, particle identification, and sub-10 &micro;m particles.
  • Packaging & devices: understanding contributions from containers, delivery systems, and packaging components.
  • Clinical relevance & risk: connecting particle type, size, source, and quantity with patient risk and appropriate controls.

Required Expertise:

  • Particulate matter science: formation, sources, classification, and behavior of inherent, intrinsic, and extrinsic particles.
  • Analytical characterization: light obscuration, microscopy, flow imaging, particle identification, orthogonal methods, and sub-10 &micro;m characterization.
  • Biologics/protein therapeutics: protein aggregation and inherent proteinaceous particles, particularly where conventional particle limits may not be straightforward.
  • Silicone oil: silicone-oil droplets from prefilled syringes, differentiation from protein/other particles, and appropriate analytical strategies.
  • Advanced modalities: cell & gene therapies, LNPs, viral vectors, and other products where the product itself can complicate particle measurement.
  • Ophthalmic products: formulation, administration route, particle-control expectations, and ophthalmic-specific patient risks.
  • Packaging & delivery systems: prefilled syringes, vials, stoppers, devices, container-closure systems, and their potential contribution to particles.
  • Clinical/toxicological risk: linking particle size, type, quantity, route of administration, and patient exposure to clinical relevance.
  • Manufacturing & process control: particle sources, investigations, PPQ, sampling strategies, trending, root-cause analysis, and lifecycle control.
  • Compendial/regulatory standards: strong knowledge of USP particulate-matter chapters and the panel’s work to reimagine the <1788> series for current and emerging products.
More about this job

Skills

  • Packaging
  • Manufacturing processes
  • Root cause analysis

Report this job

Get in touch
MovoJobs

How can we help?